Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for HeartBeam, Inc. (BEAT : NSDQ)
 
 • Company Description   
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.44 Daily Weekly Monthly
20 Day Moving Average: 32,684,490 shares
Shares Outstanding: 34.44 (millions)
Market Capitalization: $84.04 (millions)
Beta: -0.57
52 Week High: $4.00
52 Week Low: $0.54
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 216.88% 213.19%
12 Week 25.13% 21.26%
Year To Date 6.09% -9.96%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2118 Walsh Avenue Suite 210
-
Santa Clara,CA 95050
USA
ph: 408-899-4443
fax: -
beat@mzgroup.us http://www.heartbeam.com
 
 • General Corporate Information   
Officers
Robert Eno - Chief Executive Officer
Richard Ferrari - Executive Chairman
Timothy Cruickshank - Chief Financial Officer
George de Urioste - Director
Willem Elfrink - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 42238H108
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 03/12/26
Share - Related Items
Shares Outstanding: 34.44
Most Recent Split Date: (:1)
Beta: -0.57
Market Capitalization: $84.04 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/12/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 206.21
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 21.05%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
09/30/25 - -598.94
06/30/25 - -447.96
03/31/25 - -358.33
ROA
09/30/25 - -388.32
06/30/25 - -325.23
03/31/25 - -278.76
Current Ratio
09/30/25 - 0.86
06/30/25 - 2.98
03/31/25 - 5.45
Quick Ratio
09/30/25 - 0.86
06/30/25 - 2.98
03/31/25 - 5.46
Operating Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Net Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Pre-Tax Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Book Value
09/30/25 - 0.01
06/30/25 - 0.12
03/31/25 - 0.22
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©